Photo creation by RRy Publications LLC Source: Bioventus LLC
Smith & Nephew’s deal with Essex Woodlands to spin off its clinical therapies business into a new company, called Bioventus, raises the specter of a well-capitalized, nimble and aggressive biologic/injectables challenge to the metal and plastic implant business. Is SNN trying to obsolete itself? Well, better them than someone else. Here’s what’s happening.
Source: Flexion Therapeutics, Inc.
One small Boston company may have the future of orthopedics in its grasp. What if steroid pain relief lasted months instead of weeks? What if the largest osteoarthritis pain relief signal ever seen was available for intra-articular injection? Well, get ready. They’re on the way.
Neuron in tissue culture. Source: Wikimedia Commons and Gerry Shaw
One Banker’s View of Orthopedics: "It’s my belief that the next wave of innovation in orthopedics is going to happen outside of big companies, where biologics technologies will be developed” So says one of the most active bankers in orthopedics – Chris Velis.
New York Stem Cell Summit 2012
Reflecting the dynamic nature of the industry, this year’s Stem Cell Summit has a record number of new presenters and one notable drop out—Geron. No question, adult stem cells are king of the hill for clinicians, but are embryonic stem cell therapies gone for good? The answer may surprise. Read on.
Inherit the Wind starring Spencer Tracy, Frederick March and Harry Morgan. Courtesy Wikimedia Commons
In the recent issue of The Spine Journal, Eugene Carragee, M.D., writes more like prosecutor-in-chief than editor-in-chief as he resumes his attack on the use of rhBMP2 and its clinical investigators. The plaintiff’s bar is cheering. But NASS members are reeling. Who to believe? Read the details here.
Image created by RRY Publications, LLC. Source: MiMedx
Question: What are three terrific new technologies or companies in orthopedics? We see new product ideas and companies every week, but these three recent candidates stood out for their innovation and practicality. See if you agree.
Image creation by RRY Publications, LLC. Source: Wikimedia Commons
Five companies, we think, stand out when it comes to non-allograft stem cells. These firms either have stem cell products on the market or are in the very advanced stages of bringing therapeutic stem cells to the rank and file orthopedic surgeon. Check it out.
1 Comment